Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
Maximilian J. Mair, Manfred Mitterer, Pia Gattinger, J.M. Berger, Wolfgang Trutschnig, Arne C. Bathke, Margaretha Gansterer, Anna S. Berghoff, Severin Laengle, L. Gottmann, Thomas Buratti, Helmuth Haslacher, Wolfgang Lamm, Markus Raderer, Selma Tobudic, Thorsten Fuereder, Rudolf Valenta, Dominic Fong, Matthias Preusser
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Hematologic Neoplasms2019-20 coronavirus outbreakVirologyMedicineSolid tumorCancer researchImmunologyCancerInternal medicineInfectious disease (medical specialty)DiseaseOutbreakCOVID-19 and healthcare impactsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies